Unknown

Dataset Information

0

The Role of IL-9 Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma.


ABSTRACT: Recent studies have described the dichotomous function of IL-9 in various cancer diseases. However, its function has still not been analysed in laryngeal squamous cell carcinoma (LSCC). In the present study, we evaluated five single nucleotide polymorphisms (SNPs) of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) and determined their associations with the patients' five-year survival rate. Additionally, we analysed serum IL-9 levels using an enzyme-linked immunosorbent assay. Three hundred LSCC patients and 533 control subjects were included in this study. A significant association between the patients' survival rate and distribution of IL-9 rs1859430 variants was revealed: patients carrying AA genotype had a higher risk of dying (p = 0.005). Haplotypes A-G-C-G-G of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) were associated with 47% lower odds of LSCC occurrence (p = 0.035). Serum IL-9 levels were found detectable in three control group subjects (8.99 ± 12.03 pg/mL). In summary, these findings indicate that the genotypic distribution of IL-9 rs1859430 negatively influences the five-year survival rate of LSCC patients. The haplotypes A-G-C-G-G of IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, and rs2069884) are associated with the lower odds of LSCC development.

SUBMITTER: Pasvenskaite A 

PROVIDER: S-EPMC8001846 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7796822 | biostudies-literature
| S-EPMC9331506 | biostudies-literature
| S-EPMC5346738 | biostudies-literature
| S-EPMC5321498 | biostudies-literature
| S-EPMC6934856 | biostudies-literature
| S-EPMC6867599 | biostudies-literature
| S-EPMC6886334 | biostudies-literature
| S-EPMC4616331 | biostudies-literature
| S-EPMC8263688 | biostudies-literature
| S-EPMC4925956 | biostudies-literature